T. Rowe Price Tax Exempt Money Fund Inc.
10/23/2024 | Press release | Distributed by Public on 10/23/2024 08:23
Semi Annual Report by Investment Company Form N CSRS
Tax-Exempt Money Fund_TEM_F52-051
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-03055
T. Rowe Price Tax-ExemptMoney Fund, Inc.
(Exact name of registrant as specified in charter)
100 East Pratt Street, Baltimore, MD 21202
(Address of principal executive offices)
David Oestreicher
100 East Pratt Street, Baltimore, MD 21202
(Name and address of agent for service)
Registrant's telephone number, including area code: (410) 345-2000
Date of fiscal year end: February 28
Date of reporting period: August 31, 2024
Item 1. Reports to Shareholders
(a) Report pursuant to Rule 30e-1
Semi-Annual Shareholder Report
August 31, 2024
Tax-Exempt Money Fund
Investor Class (PTEXX)
This semi-annual shareholder report contains important information about Tax-Exempt Money Fund (the "fund") for the period of March 1, 2024 to August 31, 2024. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or contacting your intermediary.
What were the fund costs for the last six months? (based on a hypothetical $10,000 investment)
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
|
Tax-Exempt Money Fund - Investor Class
|
$23
|
0.45%
|
What are some fund statistics?
Fund Statistics
|
Total Net Assets (000s)
|
$660,947
|
|
Number of Portfolio Holdings
|
219
|
What did the fund invest in?
SecurityAllocation (as a % of Net Assets)
|
Variable Rate Demand Notes
|
39.2%
|
|
Other Municipal Security
|
36.4
|
|
Non-Financial Company Commercial Paper
|
24.2
|
|
Other Assets less Liabilities
|
0.2
|
Top Ten Holdings(as a % of Net Assets)
|
Tarrant County Cultural Ed. Fac. Fin., Texas Health Resources System
|
1.6%
|
|
Indiana Univ.
|
1.5
|
|
Harris County Cultural Ed. Fac.
|
1.5
|
|
Houston Combined Utility System
|
1.5
|
|
Missouri HEFA, SSM Health Care
|
1.5
|
|
California Statewide Communities Dev. Auth.
|
1.4
|
|
Oregon DOT
|
1.4
|
|
Texas A&M Univ.
|
1.4
|
|
New York City Transational Fin. Auth., Tender Option Bond Trust Receipts
|
1.4
|
|
Loudoun County Economic Dev. Auth., Howard Hughes Medical
|
1.4
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
202407-3695759
F52-053 10/24
Tax-Exempt Money Fund
Investor Class (PTEXX)
T. Rowe Price Investment Services, Inc.
100 East Pratt Street
Baltimore, MD 21202
Semi-Annual Shareholder Report
August 31, 2024
Tax-Exempt Money Fund
I Class (TERXX)
This semi-annual shareholder report contains important information about Tax-Exempt Money Fund (the "fund") for the period of March 1, 2024 to August 31, 2024. You can find the fund's prospectus, financial information on Form N-CSR (which includes required tax information for dividends), holdings, proxy voting information, and other information atwww.troweprice.com/prospectus. You can also request this information without charge by contacting T. Rowe Price at 1-800-638-5660 or [email protected]or contacting your intermediary.
What were the fund costs for the last six months? (based on a hypothetical $10,000 investment)
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment
|
|
|
Tax-Exempt Money Fund - I Class
|
$12
|
0.24%
|
What are some fund statistics?
Fund Statistics
|
Total Net Assets (000s)
|
$660,947
|
|
Number of Portfolio Holdings
|
219
|
What did the fund invest in?
SecurityAllocation (as a % of Net Assets)
|
Variable Rate Demand Notes
|
39.2%
|
|
Other Municipal Security
|
36.4
|
|
Non-Financial Company Commercial Paper
|
24.2
|
|
Other Assets less Liabilities
|
0.2
|
Top Ten Holdings(as a % of Net Assets)
|
Tarrant County Cultural Ed. Fac. Fin., Texas Health Resources System
|
1.6%
|
|
Indiana Univ.
|
1.5
|
|
Harris County Cultural Ed. Fac.
|
1.5
|
|
Houston Combined Utility System
|
1.5
|
|
Missouri HEFA, SSM Health Care
|
1.5
|
|
California Statewide Communities Dev. Auth.
|
1.4
|
|
Oregon DOT
|
1.4
|
|
Texas A&M Univ.
|
1.4
|
|
New York City Transational Fin. Auth., Tender Option Bond Trust Receipts
|
1.4
|
|
Loudoun County Economic Dev. Auth., Howard Hughes Medical
|
1.4
|
If you invest directly with T. Rowe Price, you can elect to receive future shareholder reports or other important documents through electronic delivery by enrolling at www.troweprice.com/paperless. If you invest through a financial intermediary such as an investment advisor, a bank, retirement plan sponsor or a brokerage firm, please contact that organization and ask if it can provide electronic delivery.
202407-3695759
F1103-053 10/24
Tax-Exempt Money Fund
I Class (TERXX)
T. Rowe Price Investment Services, Inc.
100 East Pratt Street
Baltimore, MD 21202
Item 1. (b) Notice pursuant to Rule 30e-3.
Not applicable.
Item 2. Code of Ethics.
A code of ethics, as defined in Item 2 of Form N-CSR,applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions is filed as an exhibit to the registrant's annual Form N-CSR.No substantive amendments were approved or waivers were granted to this code of ethics during the registrant's most recent fiscal half-year.
Item 3. Audit Committee Financial Expert.
Disclosure required in registrant's annual Form N-CSR.
Item 4. Principal Accountant Fees and Services.
Disclosure required in registrant's annual Form N-CSR.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 7 of this Form N-CSR.
(b) Not applicable.
Item 7. Financial Statements and Financial Highlights for Open-EndManagement Investment Companies.
(a - b) Report pursuant to Regulation S-X.
Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
August
31,
2024
Financial
Statements
and
Other
Information
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
T.
ROWE
PRICE
PTEXX
Tax-Exempt
Money
Fund
-!
TERXX
Tax-Exempt
Money
Fund-
.
I Class
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
(Unaudited)
Financial
Highlights
2
For
a
share
outstanding
throughout
each
period
Investor
Class
6
Months
.
Ended
8/31/24
..
Year
..
..
Ended
.
2/29/24
2/28/23
2/28/22
2/28/21
2/29/20
NET
ASSET
VALUE
Beginning
of
period
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
Investment
activities
Net
investment
income
(1)(2)
0
.02
0
.03
0
.01
(3)
-
(3)
(4)
-
(3)
(4)
0
.01
Net
realized
and
unrealized
gain/
loss
-
(4)
-
(4)
-
(4)
-
(4)
-
(4)
-
(4)
Total
from
investment
activities
0
.02
0
.03
0
.01
-
(4)
-
(4)
0
.01
Distributions
Net
investment
income
(
0
.02
)
(
0
.03
)
(
0
.01
)
-
(4)
-
(4)
(
0
.01
)
NET
ASSET
VALUE
End
of
period
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
(Unaudited)
Financial
Highlights
3
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Investor
Class
6
Months
.
Ended
8/31/24
..
Year
..
..
Ended
.
2/29/24
2/28/23
2/28/22
2/28/21
2/29/20
Ratios/Supplemental
Data
Total
return
(2)(5)
1
.55
%
3
.04
%
1
.20
%
(3)
0
.02
%
(3)
0
.19
%
(3)
1
.01
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
0
.45
%
(6)
0
.41
%
0
.44
%
0
.36
%
0
.52
%
0
.55
%
Net
expenses
after
waivers/
payments
by
Price
Associates
0
.45
%
(6)
0
.41
%
0
.42
%
(3)
0
.08
%
(3)
0
.22
%
(3)
0
.43
%
Net
investment
income
3
.07
%
(6)
2
.98
%
1
.15
%
(3)
0
.01
%
(3)
0
.17
%
(3)
1
.00
%
Net
assets,
end
of
period
(in
thousands)
$153,198
$170,492
$176,009
$274,397
$343,697
$240,329
0
%
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(3)
Includes
the
effect
of
voluntary
management
fee
waivers
and
operating
expense
reimbursements
(0.02%,
0.27%
and
0.19%
of
average
net
assets)
for
the
years
ended
2/28/23,
2/28/22
and
2/28/21,
respectively.
(4)
Amounts
round
to
less
than
$0.01
per
share.
(5)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(6)
Annualized
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
(Unaudited)
Financial
Highlights
4
For
a
share
outstanding
throughout
each
period
I
Class
6
Months
.
Ended
8/31/24
..
Year
..
..
Ended
.
2/29/24
2/28/23
2/28/22
2/28/21
2/29/20
NET
ASSET
VALUE
Beginning
of
period
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
Investment
activities
Net
investment
income
(1)(2)
0
.02
0
.03
0
.01
(3)
-
(3)
(4)
-
(3)
(4)
0
.01
Net
realized
and
unrealized
gain/
loss
-
(4)
-
(4)
-
(4)
-
(4)
-
(4)
-
(4)
Total
from
investment
activities
0
.02
0
.03
0
.01
-
(4)
-
(4)
0
.01
Distributions
Net
investment
income
(
0
.02
)
(
0
.03
)
(
0
.01
)
-
(4)
-
(4)
(
0
.01
)
NET
ASSET
VALUE
End
of
period
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
$
1
.00
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
(Unaudited)
Financial
Highlights
5
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
I
Class
6
Months
.
Ended
8/31/24
..
Year
..
..
Ended
.
2/29/24
2/28/23
2/28/22
2/28/21
2/29/20
Ratios/Supplemental
Data
Total
return
(2)(5)
1
.66
%
3
.22
%
1
.39
%
(3)
0
.02
%
(3)
0
.20
%
(3)
1
.11
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
0
.26
%
(6)
0
.25
%
0
.26
%
0
.27
%
0
.45
%
0
.46
%
Net
expenses
after
waivers/
payments
by
Price
Associates
0
.24
%
(6)
0
.25
%
0
.24
%
(3)
0
.08
%
(3)
0
.21
%
(3)
0
.33
%
Net
investment
income
3
.28
%
(6)
3
.15
%
1
.41
%
(3)
0
.01
%
(3)
0
.19
%
(3)
1
.09
%
Net
assets,
end
of
period
(in
thousands)
$507,749
$505,688
$487,066
$362,029
$191,423
$137,967
0
%
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
Includes
the
impact
of
expense-related
arrangements
with
Price
Associates.
(3)
Includes
the
effect
of
voluntary
management
fee
waivers
and
operating
expense
reimbursements
(0.00%,
0.17%
and
0.12%
of
average
net
assets)
for
the
years
ended
2/28/23,
2/28/22
and
2/28/21,
respectively.
(4)
Amounts
round
to
less
than
$0.01
per
share.
(5)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(6)
Annualized
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
August
31,
2024
(Unaudited)
6
Portfolio
of
Investments
‡
Par
$
Value
(Amounts
in
000s)
‡
NON-FINANCIAL
COMPANY
COMMERCIAL
PAPER 24.2%
California
EFA,
Stanford
Univ.,
TECP,
3.58%,
2/18/25
250
250
California
Statewide
Communities
Dev.
Auth.,
Series 08-C,
TECP,
3.60%,
10/2/24
375
375
California
Statewide
Communities
Dev.
Auth.,
Series 9B-1,
TECP,
3.65%,
9/11/24
6,700
6,700
California
Statewide
Communities
Dev.
Auth.,
Series 9B-4,
TECP,
3.68%,
9/5/24
2,500
2,500
Florida
Local
Government
Finance
Commission,
Series A-1,
TECP,
3.54%,
10/3/24
2,991
2,991
Georgia
Municipal
Electric
Auth.,
Series B,
TECP,
3.35%,
12/10/24
6,500
6,500
Harris
County
Cultural
Ed.
Fac.,
Series B-2,
TECP,
3.67%,
9/24/24
3,400
3,400
Harris
County
Cultural
Ed.
Fac.,
Series B-3,
TECP,
3.70%,
9/24/24
6,600
6,600
Harris
County
Cultural
Ed.
Fac.
Fin.,
Methodist
Health,
Series 9C-1,
TECP,
3.83%,
9/3/24
5,450
5,450
Houston
Higher
Education
Fin.,
Series A,
TECP,
3.35%,
11/19/24
1,755
1,755
Houston
Higher
Education
Fin.,
Series A,
TECP,
3.62%,
9/18/24
3,800
3,800
Houston
Higher
Education
Fin.,
Series A,
TECP,
3.66%,
9/26/24
700
700
Illinois
EFA,
TECP,
3.30%,
10/29/24
6,700
6,700
Indiana
Univ.,
TECP,
3.65%,
9/9/24
6,500
6,500
Indiana
Univ.,
TECP,
3.65%,
9/9/24
3,700
3,700
Jacksonville,
Mayo
Health
Clinic,
Series 2016,
TECP,
3.10%,
2/20/25
4,000
4,000
Los
Angeles
County,
Capital
Asset
Leasing,
Series D,
TECP,
3.55%,
10/2/24
2,750
2,750
Maryland
HHEFA,
Johns
Hopkins
Health
Systems,
Series B,
TECP,
3.47%,
10/9/24
2,865
2,865
Metropolitan
Govt.
Nashville
&
Davidson,
TECP,
3.41%,
10/7/24
2,100
2,100
Metropolitan
Govt.
Nashville
&
Davidson,
Water
&
Sewer
Auth.,
Series 2022,
TECP,
3.25%,
10/3/24
300
300
Metropolitan
Govt.
Nashville
&
Davidson,
Water
&
Sewer
Auth.,
Series 2022,
TECP,
3.36%,
11/18/24
6,500
6,500
New
York
Power
Auth.,
Series 2,
TECP,
3.27%,
10/3/24
6,500
6,500
New
York
State
Dormitory
Auth.,
TECP,
3.40%,
12/10/24
2,000
2,000
Ohio
Higher
Ed.
Fac.
Commission,
Series B-5,
TECP,
3.38%,
11/19/24
2,945
2,945
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
7
Par
$
Value
(Amounts
in
000s)
Ohio
Higher
Ed.
Fac.
Commission,
Series B-5,
TECP,
3.63%,
10/2/24
3,600
3,600
Oregon
DOT,
Series A-1,
TECP,
3.32%,
11/21/24
2,400
2,400
Oregon
DOT,
Series A-1,
TECP,
3.33%,
10/24/24
5,100
5,100
Oregon
DOT,
Series A-2,
TECP,
3.30%,
11/21/24
2,000
2,000
San
Diego
Public
Fac.
Fin.
Auth.,
Series A,
TECP,
3.65%,
10/9/24
6,500
6,500
San
Francisco
Airport
Commercial,
Series B-5,
TECP,
3.15%,
12/3/24
5,000
5,000
Santa
Clara
Valley
Water
Dist.,
TECP,
3.65%,
9/5/24
6,600
6,600
South
Carolina
Public
Service
Auth.,
Series A,
TECP,
3.30%,
10/9/24
3,000
3,000
Tennessee,
Series 00-A,
TECP,
3.42%,
12/11/24
2,000
2,000
Texas
A&M
Univ.,
Series A,
TECP,
3.55%,
1/7/25
5,500
5,500
Texas
A&M
Univ.,
Series B,
TECP,
3.31%,
12/2/24
4,000
4,000
Univ.
of
Houston,
Series A,
TECP,
3.49%,
9/10/24
2,200
2,200
Univ.
of
Houston,
Series A,
TECP,
3.60%,
9/10/24
3,000
3,000
Univ.
of
Michigan,
Series B,
TECP,
3.40%,
10/21/24
6,500
6,500
Univ.
of
Minnesota,
Series F,
TECP,
3.40%,
11/13/24
8,000
8,000
Univ.
of
Texas,
Board
of
Regents,
Series A,
TECP,
3.20%,
2/5/25
6,600
6,600
Total
Non-Financial
Company
Commercial
Paper
(Cost
$159,881)
159,881
OTHER
MUNICIPAL
SECURITY 36.4%
Berkeley
County
School
Dist.,
Series A,
GO,
5.00%,
6/2/25 (1)
4,000
4,059
Broward
County,
Water
&
Sewer
Auth., Tender
Option
Bond
Trust
Receipts,
Series 2024-XL0551,
VRTR,
2.95%,
9/9/24 (2)
2,230
2,230
California,
5.00%,
9/1/24
450
450
California,
Construction
Bonds,
GO,
4.00%,
10/1/24
2,155
2,155
California,
Tender
Option
Bond
Trust
Receipts,
Series 2018-
YX1084,
GO,
VRTR,
2.92%,
9/9/24 (2)
4,000
4,000
California,
Tender
Option
Bond
Trust
Receipts,
Series 2023-
XL0501,
GO,
VRTR,
2.95%,
9/9/24 (2)
2,375
2,375
California,
Various
Purpose,
GO,
4.00%,
11/1/24
625
625
Charleston
County
School
Dist.,
Sales
Tax
Project,
Series B,
GO,
BAN,
4.75%,
5/8/25
3,000
3,023
Clark
County,
Flood
Control,
GO,
5.00%,
11/1/24
350
351
Clark
County,
Park
Improvement,
GO,
5.00%,
12/1/24
750
752
Clark
County,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZL0480,
GO,
VRTR,
2.95%,
9/9/24 (2)
3,275
3,275
Cobb
County
School
Dist.,
Short
Term
Constructions,
GO,
4.00%,
12/16/24
6,300
6,312
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
8
Par
$
Value
(Amounts
in
000s)
Colorado
HFA,
AdventHealth
Obligated
Group,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XG0491,
VRTR,
2.95%,
9/9/24 (2)
1,730
1,730
Colorado
HFA,
Adventist
Health
System,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XM1124,
VRTR,
2.95%,
9/9/24 (2)
4,690
4,690
Colorado
HFA,
Intermountain
Healthcare,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XF1619,
VRTR,
2.95%,
9/9/24 (2)
4,000
4,000
Dist.
of
Columbia
Water
&
Sewer
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZL0506,
VRTR,
2.95%,
9/9/24 (2)
1,330
1,330
Fairfax
County,
Series A,
GO,
5.00%,
10/1/24
665
666
Franklin
County,
Trinity
Health
Credit
Group,
Series OH,
VR,
3.50%,
11/1/24
(Tender)
5,600
5,600
Harris
County
Cultural
Ed.
Fac.
Fin.,
Memorial
Hermann
Health
System,
Series A,
4.00%,
7/1/25
1,550
1,555
Harris
County
Cultural
Ed.
Fac.
Fin.,
Texas
Children's
Hospital,
5.00%,
10/1/24
525
526
Harris
County
Cultural
Ed.
Fac.
Fin.,
Texas
Children's
Hospital,
Series B,
VR,
5.00%,
10/1/24
(Tender)
6,900
6,965
Harris
County,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XG0516,
GO,
VRTR,
2.95%,
9/9/24 (2)
2,160
2,160
Hawaii,
Series EZ,
GO,
5.00%,
10/1/24
1,130
1,131
Hawaii,
Series FN,
GO,
5.00%,
10/1/24
775
776
Illinois
Fin.
Auth.,
Northwestern
Univ.,
5.00%,
12/1/24
1,290
1,294
Illinois
Toll
Highway
Auth.,
Series B,
5.00%,
1/1/25
405
407
Indiana
Fin.
Auth.,
Indiana
Univ.,
Series 2014A,
5.00%,
12/1/24
385
386
Indiana
Fin.
Auth.,
Indiana
Univ.,
Series 2016A,
5.00%,
12/1/24
525
526
Indiana
HFFA,
Ascension
Health,
Series A-7,
4.00%,
10/1/24
865
865
JPMorgan
Chase
Putters,
Series 2024-5067,
VRTR,
2.95%,
9/9/24 (2)
4,000
4,000
Los
Angeles,
TRAN,
5.00%,
6/26/25
3,000
3,037
Los
Angeles
Dept.
of
Water
&
Power,
Tender
Option
Bond
Trust
Receipts,
Series 2022-ZL0326,
VRTR,
2.93%,
9/9/24 (2)
1,330
1,330
Maricopa
County
IDA,
Banner
Health,
Series A,
5.00%,
1/1/25
1,000
1,004
Maricopa
County
IDA,
Banner
Health,
Series C,
VR,
5.00%,
10/18/24
(Tender)
5,340
5,373
Maryland
DOT,
5.00%,
10/1/24
345
345
Massachusetts
Dev.
Fin.
Agency,
Partners
Healthcare,
Series S-2,
VR,
5.00%,
1/30/25
(Tender)
565
569
Massachusetts,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZL0524,
GO,
VRTR,
2.92%,
9/9/24 (2)
1,500
1,500
Michigan
Fin.
Auth.,
Series A-2,
5.00%,
8/20/25
6,500
6,603
Michigan
Hosp.
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-ZF1401,
VRTR,
2.95%,
9/9/24 (2)
1,250
1,250
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
9
Par
$
Value
(Amounts
in
000s)
Monmouth
County
Improvement
Auth.,
Government
Pooled
Loan
Project,
4.00%,
3/14/25
5,580
5,598
Montgomery
County,
Trinity
Health
Credit
Group,
Series 2013MD,
VR,
3.70%,
9/3/24
(Tender)
1,000
1,000
Montgomery
County,
Trinity
Health
Credit
Group,
Series 2013MD,
VR,
3.70%,
9/3/24
(Tender)
1,000
1,000
Nebraska
Investment
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2024-XL0563,
VRTR,
2.95%,
9/9/24 (2)
2,000
2,000
Nebraska
Investment
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2024-YX1334,
VRTR,
2.95%,
9/9/24 (2)
1,545
1,545
Nebraska
Investment
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2024-YX1335,
VRTR,
2.95%,
9/9/24 (2)
1,910
1,910
Nebraska
Investment
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2024-ZF1734,
VRTR,
2.95%,
9/9/24 (2)
2,220
2,220
New
York,
Series B-1,
GO,
5.00%,
10/1/24
1,000
1,001
New
York,
Series F-3,
GO,
5.00%,
12/1/24
825
828
New
York
City
Housing
Dev.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XF1702,
VRTR,
2.95%,
9/9/24 (2)
3,200
3,200
New
York
City
Municipal
Water
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XL0375,
VRTR,
2.95%,
9/9/24 (2)
4,040
4,040
New
York
City
Municipal
Water
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XL0376,
VRTR,
2.95%,
9/9/24 (2)
2,250
2,250
New
York
City
Municipal
Water
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XL0378,
VRTR,
2.95%,
9/9/24 (2)
915
915
New
York
City
Transational
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XF1587,
VRTR,
2.95%,
9/9/24 (2)
2,600
2,600
New
York
City
Transational
Fin.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XG0524,
VRTR,
2.95%,
9/9/24 (2)
6,840
6,840
New
York
City,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XX1230,
GO,
VRTR,
2.95%,
9/9/24 (2)(3)
4,325
4,325
New
York
Power
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XL0416,
VRTR,
2.95%,
9/9/24 (2)
2,060
2,060
New
York
State
Development,
Tender
Option
Bond
Trust
Receipts,
Series 2022-ZL0347,
VRTR,
2.95%,
9/9/24 (2)
1,560
1,560
New
York
State
Dormitory
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XM1052,
VRTR,
2.95%,
9/9/24 (2)
5,625
5,625
New
York
State
Dormitory
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZF3171,
VRTR,
2.95%,
9/9/24 (2)
2,125
2,125
New
York
State
Dormitory
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2024-XF1735,
VRTR,
2.95%,
9/9/24 (2)
1,080
1,080
New
York
State
Environmental
Fac.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XF3049,
VRTR,
2.95%,
9/9/24 (2)
2,670
2,670
New
York
State
Environmental
Fac.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XF1442,
VRTR,
2.95%,
9/9/24 (2)
3,560
3,560
Ohio,
Cleveland
Clinic
Health
System,
Series A,
5.00%,
1/1/25
440
442
Ohio,
Common
School,
Series B,
GO,
5.00%,
9/15/24
975
975
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
10
Par
$
Value
(Amounts
in
000s)
Ohio,
Infrastructure
Improvement,
Series A,
5.00%,
9/1/24
710
710
Ohio,
Infrastructure
Improvement,
Series C,
GO,
5.00%,
3/1/25
500
503
Oklahoma
Trunpike
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZF1636,
VRTR,
2.95%,
9/9/24 (2)
2,780
2,780
Pennsylvania
Housing
Fin.
Agency,
Tender
Option
Bond
Trust
Receipts,
Series 2024-XF1737,
VRTR,
2.95%,
9/9/24 (2)
2,500
2,500
Prince
George's
County,
Consolidated
Public
Improvement,
Series A,
GO,
5.00%,
9/15/24
200
200
RIB
Floster,
Tender
Option
Bond
Trust
Receipts,
Series 2016-
XM0435,
VRTR,
2.95%,
9/9/24 (2)
7,000
7,000
Riverhead
Central
School
Dist.,
Series B,
GO,
TAN,
4.00%,
6/25/25 (1)
2,500
2,516
Salt
River
Project
Agricultural
Improvement
&
Power
Dist.,
Series 2016A,
5.00%,
1/1/25
475
477
Salt
River
Project
Agricultural
Improvement
&
Power
Dist.,
Series 2021A,
5.00%,
1/1/25
815
819
San
Antonio,
GO,
5.00%,
2/1/25
395
397
South
Carolina
Assn.
of
Governmental
Organizations,
Series A,
COP,
4.50%,
2/28/25
5,315
5,338
South
Dakota
Housing
Dev.
Auth.,
Series J,
VR,
3.875%,
12/12/24
(Tender)
6,500
6,500
Tarrant
County
Cultural
Ed.
Fac.
Fin.,
Baylor
Scott
&
White
Health
Project,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZF1668,
VRTR,
2.95%,
9/9/24 (2)
2,260
2,260
Tarrant
County
Cultural
Ed.
Fac.
Fin.,
Texas
Health
Resources
System,
Series A,
5.00%,
2/15/25
695
699
Texas
Transportation
Commission
State
Highway
Fund,
1st
Tier,
5.00%,
10/1/24
1,725
1,727
Triborough
Bride
&
Tunnel
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XF1357,
VRTR,
2.96%,
9/9/24 (2)
3,750
3,750
Triborough
Bride
&
Tunnel
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XF1359,
VRTR,
2.96%,
9/9/24 (2)
2,250
2,250
Triborough
Bride
&
Tunnel
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XF1495,
VRTR,
2.95%,
9/9/24 (2)
1,565
1,565
Univ.
of
California
Regents
Medical
Center, Tender
Option
Bond
Trust
Receipts,
Series 2023-YX1294,
VRTR,
2.95%,
9/9/24 (2)
1,875
1,875
Univ.
of
California
Regents
Medical
Center, Tender
Option
Bond
Trust
Receipts,
Series 2024-XL0552,
VRTR,
2.95%,
9/9/24 (2)
1,875
1,875
Univ.
of
California
Regents
Medical
Center,
Tender
Option
Bond
Trust
Receipts,
Series 2018-YX1098,
VRTR,
2.94%,
9/9/24 (2)
2,900
2,900
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
11
Par
$
Value
(Amounts
in
000s)
Univ.
of
California
Regents
Medical
Center,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XX1258,
VRTR,
2.94%,
9/9/24 (2)
2,000
2,000
Univ.
of
California,
Tender
Option
Bond
Trust
Receipts,
Series 2022-XX1263,
VRTR,
2.94%,
9/9/24 (2)
1,875
1,875
Univ.
of
California,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XF3164,
VRTR,
2.94%,
9/9/24 (2)
3,000
3,000
Univ.
of
California,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XX1325,
VRTR,
2.94%,
9/9/24 (2)
2,500
2,500
Univ.
of
Houston,
Board
of
Regents,
Series A,
5.00%,
2/15/25
1,235
1,243
Virginia
Housing
Dev.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2023-XL0489,
VRTR,
2.95%,
9/9/24 (2)
1,800
1,800
Virginia
Housing
Dev.
Auth.,
Tender
Option
Bond
Trust
Receipts,
Series 2024-XM1176,
VRTR,
2.95%,
9/9/24 (2)
3,300
3,300
Virginia
Public
School
Auth.,
Technology
and
Security,
Series X,
5.00%,
4/15/25
560
565
Washington
State,
Tender
Option
Bond
Trust
Receipts,
Series 2022-ZF1403,
GO,
VRTR,
2.95%,
9/9/24 (2)
1,675
1,675
Washington
State,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZL0490,
GO,
VRTR,
2.95%,
9/9/24 (2)
1,665
1,665
Washington
State,
Tender
Option
Bond
Trust
Receipts,
Series 2023-ZL0491,
GO,
VRTR,
2.95%,
9/9/24 (2)
1,665
1,665
Washington
State,
Tender
Option
Bond
Trust
Receipts,
Series 2024-CF7002,
VRTR,
2.94%,
9/9/24 (2)
3,200
3,200
Wichita
City,
Series 314,
GO,
5.00%,
10/15/24
5,000
5,008
Wisconsin
HEFA,
Advocate
Aurora
Health
Credit
Group,
Series B-4,
VR,
5.00%,
1/29/25
(Tender)
2,500
2,522
Wisconsin
HEFA,
Ascension
Health,
Series A,
5.00%,
11/15/24
625
627
Wisconsin
HEFA,
Tender
Option
Bond
Trust
Receipts,
Series 2024-XF1696,
VRTR,
2.95%,
9/9/24 (2)
2,840
2,840
Wisconsin
Housing
&
Economic
Dev.
Auth., Tender
Option
Bond
Trust
Receipts,
Series 2024-XL0554,
VRTR,
2.95%,
9/9/24 (2)
5,760
5,760
Total
Other
Municipal
Security
(Cost
$240,480)
240,480
VARIABLE
RATE
DEMAND
NOTES 39.2%
Alaska
Housing
Fin.,
Home
Mortgage,
Series B,
VRDN,
2.90%,
9/9/24
3,255
3,255
Battery
Park
City
Auth.,
Series D-2,
VRDN,
3.80%,
9/3/24
260
260
Charlotte-Mecklenburg
Hosp.
Auth.,
Atrium
Healthcare,
Series E,
VRDN,
3.97%,
9/3/24
350
350
Clark
County
Dept.
of
Aviation,
Series D-2B,
VRDN,
3.00%,
9/9/24
6,275
6,275
Connecticut
HEFA,
Series O,
VRDN,
3.50%,
9/9/24
3,500
3,500
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
12
Par
$
Value
(Amounts
in
000s)
Dallas
Performing
Arts
Cultural
Fac.,
Series A,
VRDN,
3.01%,
9/9/24
2,515
2,515
Dallas
Performing
Arts
Cultural
Fac.,
Series B,
VRDN,
3.05%,
9/9/24
1,805
1,805
Delaware
Valley
Regional
Fin.
Auth.,
Series B,
VRDN,
2.90%,
9/9/24
7,005
7,005
Dist.
of
Columbia,
VRDN,
3.01%,
9/9/24
920
920
Dist.
of
Columbia
Water
&
Sewer
Auth.,
Series B-2,
VRDN,
2.96%,
9/9/24
7,600
7,600
Franklin
County,
Nationwide
Children's
Hospital,
VRDN,
3.00%,
9/9/24
3,200
3,200
Franklin
County,
Nationwide
Children's
Hospital,
Series A,
VRDN,
3.00%,
9/9/24
200
200
Franklin
County,
Nationwide
Children's
Hospital,
Series B,
VRDN,
3.00%,
9/9/24
3,800
3,800
Harris
County
Hosp.
Dist.,
Series 2010,
VRDN,
2.98%,
9/9/24
1,865
1,865
Harrisonburg
Economic
Dev.
Auth.,
Sentara
Healthcare,
VRDN,
3.00%,
9/9/24
1,340
1,340
Highlands
County
HFA,
Hospital
Adventist
Health
System,
Series I-3,
VRDN,
2.90%,
9/9/24
2,000
2,000
Houston
Combined
Utility
System,
Series B-2,
VRDN,
2.90%,
9/9/24
2,600
2,600
Houston
Combined
Utility
System,
Series C,
VRDN,
2.90%,
9/9/24
7,350
7,350
Howard
County
Housing
Commission,
Beech's
Farm
Apartments,
VRDN,
2.90%,
9/9/24
8,890
8,890
Illinois
Fin.
Auth.,
Northwestern
Memorial
Healthcare,
Series B,
VRDN,
3.85%,
9/3/24
600
600
Illinois
Fin.
Auth.,
Univ.
of
Chicago
Medical,
Series B,
VRDN,
2.95%,
9/9/24
6,000
6,000
Indiana
Fin.
Auth.,
Ascension
Health
Alliance,
Series E-4,
VRDN,
2.85%,
9/9/24
1,300
1,300
Indiana
Fin.
Auth.,
Parkview
Health
System,
Series C,
VRDN,
2.88%,
9/9/24
220
220
Jacksonville,
Baptist
Health,
Series B,
VRDN,
3.05%,
9/9/24
6,275
6,275
JEA
Electric
System,
Series 3-A,
VRDN,
3.00%,
9/9/24
6,975
6,975
Lehigh
County,
Lehigh
Valley
Health
Network,
Series B,
VRDN,
2.93%,
9/9/24
7,095
7,095
Loudoun
County
Economic
Dev.
Auth.,
Howard
Hughes
Medical,
Series A,
VRDN,
3.05%,
9/9/24
850
850
Loudoun
County
Economic
Dev.
Auth.,
Howard
Hughes
Medical,
Series E,
VRDN,
2.75%,
9/9/24
7,075
7,075
Loudoun
County
Economic
Dev.
Auth.,
Howard
Hughes
Medical,
Series F,
VRDN,
2.75%,
9/9/24
1,235
1,235
Louisiana
Gasoline
&
Fuels
Tax,
Second
Lien,
Series A-1,
VRDN,
3.80%,
9/3/24
100
100
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
13
Par
$
Value
(Amounts
in
000s)
Louisiana
Public
Fac.
Auth.,
Louisiana
Children's
Medical
Center,
Series B,
VRDN,
2.92%,
9/9/24
8,000
8,000
Louisville
County,
Norton
Healthcare,
VRDN,
2.88%,
9/9/24
7,230
7,230
Maricopa
County
IDA,
Honor
Health,
Series C,
VRDN,
2.90%,
9/9/24
2,000
2,000
Maryland
CDA,
Kirkwood
Housing,
Series G,
VRDN,
2.90%,
9/9/24
6,425
6,425
Maryland
Economic
Dev.,
Howard
Hughes
Medical,
Series A,
VRDN,
2.85%,
9/9/24
750
750
Maryland
HHEFA,
Johns
Hopkins
Health
System,
Series C,
VRDN,
2.88%,
9/9/24
1,000
1,000
Maryland
HHEFA,
Johns
Hopkins
Univ.,
Series A,
VRDN,
2.87%,
9/9/24
2,450
2,450
Maryland
HHEFA,
Pooled
Loan
Program,
Series B,
VRDN,
2.75%,
9/9/24
475
475
Maryland
Stadium
Auth.,
Football
Stadium,
VRDN,
2.90%,
9/9/24
4,650
4,650
Metropolitan
Washington
Airports
Auth.
Aviation
Revenue,
Series D-1,
VRDN,
2.90%,
9/9/24
2,000
2,000
Mississippi
Business
Fin.,
Series A,
VRDN,
2.90%,
9/9/24
4,545
4,545
Missouri
HEFA,
BJC
Health
System,
Series C,
VRDN,
2.93%,
9/9/24
6,600
6,600
Missouri
HEFA,
SSM
Health
Care,
Series F,
VRDN,
3.00%,
9/9/24
9,500
9,500
Missouri
HEFA,
SSM
Health
Care,
Series G,
VRDN,
3.00%,
9/9/24
385
385
Montgomery
County
Housing
Opportunities
Commission,
Series C,
VRDN,
2.90%,
9/9/24
3,000
3,000
Montgomery
County
Housing
Opportunities
Commission,
Series D,
VRDN,
2.90%,
9/9/24
300
300
Montgomery
County
Housing
Opportunities
Commission,
Housing
Dev.,
Series A,
VRDN,
2.90%,
9/9/24
6,515
6,515
New
York
City
Housing
Dev.,
Series A-4,
VRDN,
2.91%,
9/9/24
2,000
2,000
New
York
City
Housing
Dev.,
201
Pearl
Street,
Multi-Family,
Series A,
VRDN,
2.79%,
9/9/24
2,315
2,315
New
York
City
Housing
Dev.,
Elliott
Chelsea
Dev.,
Series A,
VRDN,
2.95%,
9/9/24
300
300
Norfolk
Economic
Dev.
Auth.,
Sentara
Healthcare,
Series A,
VRDN,
2.85%,
9/9/24
4,205
4,205
Ohio
State
Univ.,
Multi-year
Debt
Issuance
Program
II,
Series D-2,
VRDN,
3.45%,
9/9/24
5,200
5,200
Orange
County
HFA,
Nemours
Foundation
Project,
Series B,
VRDN,
2.92%,
9/9/24
2,875
2,875
Oregon,
Veterans
Welfare,
Series P,
GO,
VRDN,
3.00%,
9/9/24
3,200
3,200
Pennsylvania
Turnpike
Commission,
VRDN,
2.98%,
9/9/24
550
550
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
14
Par
$
Value
(Amounts
in
000s)
Pennsylvania
Turnpike
Commission,
Second Series,
VRDN,
2.98%,
9/9/24
5,200
5,200
Pennsylvania
Turnpike
Commission,
Series B,
VRDN,
2.98%,
9/9/24
3,150
3,150
Private
Colleges
&
Univ.
Auth.,
Emory
Univ.,
Series B,
VRDN,
3.05%,
9/9/24
4,800
4,800
Rhode
Island
Health
&
Ed.
Building,
Series A,
VRDN,
2.90%,
9/9/24
5,470
5,470
Roanoke
Economic
Dev.
Auth.,
Carilion
Clinic
Obligated,
Series C,
VRDN,
2.90%,
9/9/24
1,185
1,185
South
Carolina
Public
Service
Auth.,
Series A,
VRDN,
3.04%,
9/9/24
4,705
4,705
South
Dakota
HEFA,
Sioux
VY
Hosp.,
Series B,
VRDN,
2.95%,
9/9/24
4,390
4,390
Tarrant
County
Cultural
Ed.
Fac.
Fin.,
Texas
Health
Resources
System,
Series A,
VRDN,
2.95%,
9/9/24
1,950
1,950
Tarrant
County
Cultural
Ed.
Fac.
Fin.,
Texas
Health
Resources
System,
Series B,
VRDN,
2.85%,
9/9/24
7,000
7,000
Tarrant
County
Cultural
Ed.
Fac.
Fin.,
Texas
Health
Resources
System,
Series C,
VRDN,
2.85%,
9/9/24
740
740
Texas,
Veterans,
GO,
VRDN,
2.85%,
9/9/24
635
635
Texas,
Veterans,
Series 2017,
GO,
VRDN,
2.85%,
9/9/24
1,640
1,640
Texas,
Veterans,
Series 2018,
GO,
VRDN,
2.85%,
9/9/24
770
770
Texas,
Veterans
Housing
Assistance
Program,
Series C,
GO,
VRDN,
2.85%,
9/9/24
2,585
2,585
Univ.
of
Colorado
Hosp.
Auth.,
Series A,
VRDN,
3.40%,
9/9/24
5,600
5,600
Utah
County,
IHC
Health
Services,
Series B,
VRDN,
3.00%,
9/9/24
2,730
2,730
Utah
County,
IHC
Health
Services,
Series C,
VRDN,
2.90%,
9/9/24
1,900
1,900
Virginia
College
Building
Auth.,
Univ.
of
Richmond
Project,
VRDN,
2.95%,
9/9/24
1,500
1,500
Virginia
Small
Business
Fin.
Auth.,
Carilion
Clinic,
Series A,
VRDN,
2.94%,
9/9/24
4,350
4,350
Virginia
Small
Business
Fin.
Auth.,
Carilion
Clinic,
Series B,
VRDN,
2.90%,
9/9/24
1,800
1,800
Wisconsin
Housing
&
Economic
Dev.
Auth.
Home
Ownership
Revenue,
Series C,
VRDN,
2.90%,
9/9/24
710
710
Wisconsin
Housing
&
Economic
Dev.
Auth.
Housing
Revenue,
Series C,
VRDN,
3.00%,
9/9/24
7,500
7,500
Total
Variable
Rate
Demand
Notes
(Cost
$259,235)
259,235
Total
Investments
in
Securities
99.8%
of
Net
Assets
(Cost
$659,596)
$
659,596
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
15
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
‡
Par
is
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
When-issued
security
(2)
Security
was
purchased
pursuant
to
Rule
144A
under
the
Securities
Act
of
1933
and
may
be
resold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers.
Total
value
of
such
securities
at
period-end
amounts
to
$144,430
and
represents
21.9%
of
net
assets.
(3)
Insured
by
Build
America
Mutual
Assurance
Company
BAN
Bond
Anticipation
Note
CDA
Community
Development
Administration/Authority
COP
Certificate
of
Participation
DOT
Department
of
Transportation
EFA
Educational
Facility
Authority
GO
General
Obligation
HEFA
Health
&
Educational
Facility
Authority
HFA
Health
Facility
Authority
HFFA
Health
Facility
Financing
Authority
HHEFA
Health
&
Higher
Educational
Facility
Authority
IDA
Industrial
Development
Authority/Agency
TAN
Tax
Anticipation
Note
TECP
Tax-Exempt
Commercial
Paper
TRAN
Tax
Revenue
Anticipation
Note
VR
Variable
Rate;
rate
shown
is
effective
rate
at
period-end.
The
rates
for
certain
variable
rate
securities
are
not
based
on
a
published
reference
rate
and
spread
but
are
determined
by
the
issuer
or
agent
and
based
on
current
market
conditions.
VRDN
Variable
Rate
Demand
Note
under
which
the
holder
has
the
right
to
sell
the
security
to
the
issuer
or
the
issuer's
agent
at
a
predetermined
price
on
specified
dates;
such
specified
dates
are
considered
the
effective
maturity
for
purposes
of
the
fund's
weighted
average
maturity;
rate
shown
is
effective
rate
at
period-end
and
maturity
date
shown
is
the
date
principal
can
be
demanded.
Certain
VRDN
rates
are
not
based
on
a
published
reference
rate
and
spread
but
may
adjust
periodically.
VRTR
Variable
Rate
Trust
Receipt
is
a
synthetic
variable
rate
instrument
which
entitles
the
holder
to
sell
the
security
to
the
issuer
or
its
agent
at
a
predetermined
price
on
specified
dates;
such
specified
dates
are
considered
the
effective
maturity
for
purposes
of
the
fund's
weighted
average
maturity;
rate
shown
is
effective
rate
at
period-end;
and
maturity
date
shown
is
the
date
principal
can
be
demanded.
Certain
VRTR
rates
are
not
based
on
a
published
reference
rate
and
spread
but
may
adjust
periodically.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
August
31,
2024
(Unaudited)
Statement
of
Assets
and
Liabilities
16
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Assets
Investments
in
securities,
at
value
(cost
$659,596)
$
659,596
Cash
5,623
Interest
receivable
4,364
Receivable
for
investment
securities
sold
1,190
Receivable
for
shares
sold
1,070
Other
assets
38
Total
assets
671,881
Liabilities
Payable
for
investment
securities
purchased
7,576
Payable
for
shares
redeemed
3,159
Investment
management
fees
payable
107
Due
to
affiliates
17
Other
liabilities
75
Total
liabilities
10,934
Commitments
and
Contingent
Liabilities
(note
5
)
NET
ASSETS
$
660,947
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
96
Paid-in
capital
applicable
to
660,065,593
shares
of
$0.01
par
value
capital
stock
outstanding;
5,000,000,000
shares
authorized
660,851
NET
ASSETS
$
660,947
NET
ASSET
VALUE
PER
SHARE
Investor
Class
(Net
assets:
$153,198;
Shares
outstanding:
152,995,093)
$
1.00
I
Class
(Net
assets:
$507,749;
Shares
outstanding:
507,070,500)
$
1.00
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
(Unaudited)
Statement
of
Operations
17
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
8/31/24
Investment
Income
(Loss)
Interest
income
$
11,872
Expenses
Investment
management
641
Shareholder
servicing
Investor
Class
$
165
I
Class
44
209
Prospectus
and
shareholder
reports
Investor
Class
1
I
Class
3
4
Custody
and
accounting
101
Registration
35
Legal
and
audit
14
Directors
1
Miscellaneous
26
Waived
/
paid
by
Price
Associates
(
39
)
Total
expenses
992
Net
investment
income
10,880
Realized
and
Unrealized
Gain
/
Loss
-
Net
realized
gain
on
securities
1
INCREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
10,881
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
(Unaudited)
Statement
of
Changes
in
Net
Assets
18
($000s)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
8/31/24
Year
Ended
2/29/24
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
income
$
10,880
$
20,527
Net
realized
gain
(loss)
1
(
1
)
Increase
in
net
assets
from
operations
10,881
20,526
Distributions
to
shareholders
Net
earnings
Investor
Class
(
2,381
)
(
5,142
)
I
Class
(
8,372
)
(
15,463
)
Decrease
in
net
assets
from
distributions
(
10,753
)
(
20,605
)
Capital
share
transactions
*
Shares
sold
Investor
Class
49,712
104,268
I
Class
99,261
193,402
Distributions
reinvested
Investor
Class
2,336
5,007
I
Class
7,919
14,607
Shares
redeemed
Investor
Class
(
69,356
)
(
114,762
)
I
Class
(
105,233
)
(
189,339
)
Increase
(decrease)
in
net
assets
from
capital
share
transactions
(
15,361
)
13,183
Net
Assets
Increase
(decrease)
during
period
(
15,233
)
13,104
Beginning
of
period
676,180
663,076
End
of
period
$
660,947
$
676,180
*
Capital
share
transactions
at
net
asset
value
of
$1.00
per
share.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
Unaudited
NOTES
TO
FINANCIAL
STATEMENTS
19
T.
Rowe
Price
Tax-Exempt
Money
Fund,
Inc. (the
fund) is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act)
as a
diversified, open-end
management
investment
company. The
fund
seeks
to
provide
preservation
of
capital,
liquidity,
and,
consistent
with
these
objectives,
the
highest
current
income
exempt
from
federal
income
taxes. The
fund
intends
to
operate
as
a
retail
money
market
fund
and
has
the
ability
to impose
liquidity
fees
on
redemptions if
the
fund's
Board
of
Directors
determine
that
doing
so
is
in
the
best
interests
of
the
shareholders.
The
fund
has two classes
of
shares:
the
Tax-Exempt
Money
Fund
(Investor
Class)
and
the
Tax-Exempt
Money
Fund-I
Class
(I
Class).
I
Class
shares
require
a
$500,000
initial
investment
minimum,
although
the
minimum
generally
is
waived
or
reduced
for
financial
intermediaries,
eligible
retirement
plans,
and
certain
other
accounts. Each
class
has
exclusive
voting
rights
on
matters
related
solely
to
that
class;
separate
voting
rights
on
matters
that
relate
to
both
classes;
and,
in
all
other
respects,
the
same
rights
and
obligations
as
the
other
class.
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES
Basis
of
Preparation
The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
Investment
Transactions,
Investment
Income,
and
Distributions
Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis. Premiums
and
discounts
on
debt
securities
are
amortized
for
financial
reporting
purposes. Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense. Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date. Income
distributions,
if
any, are
declared
by
each
class daily
and
paid
monthly. A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
20
Class
Accounting
Shareholder
servicing,
prospectus,
and
shareholder
report
expenses
incurred
by
each
class
are
charged
directly
to
the
class
to
which
they
relate.
Expenses
common
to
all
classes
and
investment
income
are
allocated
to
the
classes
based
upon
the
relative
daily
net
assets
of
each
class's
settled
shares;
realized
and
unrealized
gains
and
losses
are
allocated
based
upon
the
relative
daily
net
assets
of
each
class's
outstanding
shares.
Capital
Transactions
Each
investor's
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund's
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
Indemnification
In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund's
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
NOTE
2
-
VALUATION
The
fund's
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value.
The
fund's
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund's
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee.
The
Valuation
Designee
provides
periodic
reporting
to
the
Board
on
valuation
matters.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
21
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1 - quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2 - inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3 - unobservable
inputs
(including
the Valuation
Designee's
assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
In
accordance
with
Rule
2a-7
under
the
1940
Act,
the
fund
values
its
securities
at
amortized
cost,
which
approximates
fair
value.
Securities
for
which
amortized
cost
is
deemed
not
to
reflect
fair
value
are
stated
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee,
in
accordance
with
fair
valuation
policies
and
procedures.
On
August
31,
2024,
all
of
the
fund's
financial
instruments
were
classified
as
Level
2
in
the
fair
value
hierarchy.
NOTE
3
-
OTHER
INVESTMENT
TRANSACTIONS
Consistent
with
its
investment
objective, the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of the
fund
are
described
more
fully
in the
fund's prospectus
and
Statement
of
Additional
Information.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
22
Restricted
Securities
The
fund
invests
in
securities
that
are
subject
to
legal
or
contractual
restrictions
on
resale.
Prompt
sale
of
such
securities
at
an
acceptable
price
may
be
difficult
and
may
involve
substantial
delays
and
additional
costs.
When-Issued
Securities
The fund
enters
into
when-issued
purchase
or
sale
commitments,
pursuant
to
which
it
agrees
to
purchase
or
sell,
respectively,
an
authorized
but
not
yet
issued
security
for
a
fixed
unit
price,
with
payment
and
delivery
not
due
until
issuance
of
the
security
on
a
scheduled
future
date.
When-issued
securities
may
be
new
securities
or
securities
issued
through
a
corporate
action,
such
as
a
reorganization
or
restructuring.
Until
settlement,
the
fund
maintains
liquid
assets
sufficient
to
settle
its
commitment
to
purchase
a
when-issued
security.
Amounts
realized
on
when-issued
transactions
are
included
in
realized
gain/loss
on
securities
in
the
accompanying
financial
statements.
NOTE
4
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
Financial
reporting
records
are
adjusted
for
permanent
book/tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
amount
and
character
of
tax-basis
distributions
and
composition
of
net
assets
are
finalized
at
fiscal
year-
end;
accordingly,
tax-basis
balances
have
not
been
determined
as
of
the
date
of
this
report.
At
August
31,
2024,
the
cost
of
investments
(including
derivatives,
if
any)
for
federal
income
tax
purposes
was
$659,596,000.
NOTE
5
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group). The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee
equal
to 0.19%
of
the
fund's
average
daily
net
assets.
The
fee
is
computed
daily
and
paid
monthly.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
23
The Investor
Class is
subject
to
a
contractual
expense
limitation
through
the
expense
limitation
date
indicated
in
the
table
below.
During
the
limitation
period,
Price
Associates
is required
to
waive
or
pay
any
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary
expenses;
and
acquired
fund
fees
and
expenses)
that
would
otherwise
cause
the class's ratio
of
annualized
total
expenses
to
average
net
assets
(net
expense
ratio)
to
exceed
its
expense
limitation.
The
class
is
required
to
repay
Price
Associates
for
expenses
previously
waived/paid
to
the
extent
the
class's net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the class's net
expense
ratio
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
expense
limitation
in
place
at
the
time
such
amounts
were
waived;
or
(2)
the class's
current
expense
limitation.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
The
I
Class
is
also
subject
to
an
operating
expense
limitation
(I
Class
Limit)
pursuant
to
which
Price
Associates
is
contractually
required
to
pay
all
operating
expenses
of
the
I
Class,
excluding
management
fees;
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage; non-recurring,
extraordinary expenses; and
acquired
fund
fees
and
expenses, to
the
extent
such
operating
expenses,
on
an
annualized
basis,
exceed
the
I
Class
Limit. This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund's
Board.
The
I
Class
is
required
to
repay
Price
Associates
for
expenses
previously
paid
to
the
extent
the
class's
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class's
operating
expenses
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
I
Class
Limit
in
place
at
the
time
such
amounts
were
paid;
or
(2)
the
current
I
Class
Limit.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
Pursuant
to
these
agreements,
expenses
were waived/paid
by
and/or
repaid
to
Price
Associates
during
the six
months
ended August
31,
2024 as
indicated
in
the
table
below.
Including
these
amounts,
expenses
previously
waived/paid
by
Price
Associates
in
the
amount
of $173,000 remain
subject
to
repayment
by
the
fund
at
August
31,
2024. Any
repayment
of
expenses
previously
waived/paid
by
Price
Associates
during
the
period
would
be
included
in
the
net
investment
income
and
expense
ratios
presented
on
the
accompanying
Financial
Highlights.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
24
Price
Associates
may
voluntarily
waive
all
or
a
portion
of
its
management
fee
and
reimburse
operating
expenses
to
the
extent
necessary
for
the
fund
to
maintain
a
zero
or
positive
net
yield
(voluntary
waiver).
This
voluntary
waiver
is
in
addition
to
the
contractual
expense
limit
in
effect
for
the
fund. Any
amounts
waived/paid
by
Price
Associates
under
this
voluntary
agreement
are
not
subject
to
repayment
by
the
fund.
Price
Associates
may
amend
or
terminate
this
voluntary
arrangement
at
any
time
without
prior
notice.
For
the
six
months ended
August
31,
2024,
the
fund
had
no
voluntary
waivers.
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
a
wholly
owned
subsidiary
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund's
transfer
and
dividend-disbursing
agent.
For
the
six
months
ended
August
31,
2024,
expenses
incurred
pursuant
to
these
service
agreements
were
$56,000
for
Price
Associates
and
$171,000
for
T.
Rowe
Price
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
T.
Rowe
Price
Investment
Services,
Inc.
(Investment
Services)
serves
as
distributor
to
the
fund.
Pursuant
to
an
underwriting
agreement,
no
compensation
for
any
distribution
services
provided
is
paid
to
Investment
Services
by
the
fund
(except
for
12b-1
fees
under
a
Board-approved
Rule
12b-1
plan).
The fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund's
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
independent
current
market
price
of
the
security.
During
the
six
months
ended
August
31,
2024,
the
aggregate
value
of
purchases
and
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates
was
less
than
1%
of
the
fund's
net
assets
as
of
August
31,
2024.
Investor
Class
I
Class
Expense
limitation/I
Class
Limit
0.45%
0.05%
Expense
limitation
date
04/30/26
04/30/26
(Waived)/repaid
during
the
period
($000s)
$-
$(39)
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
25
NOTE
6
-
OTHER
MATTERS
Unpredictable environmental,
political,
social
and
economic
events,
including
but
not
limited
to,
environmental
or
natural
disasters,
war
and
conflict
(including
Russia's
military
invasion
of
Ukraine
and
the
conflict
in
Israel,
Gaza
and
surrounding
areas),
terrorism,
geopolitical
developments
(including
trading
and
tariff
arrangements,
sanctions
and
cybersecurity
attacks),
and
public
health
epidemics
(including
the
global
outbreak
of
COVID-19)
and
similar
public
health
threats,
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
a
fund
invests.
The
extent
and
duration
of
such
events
and
resulting
market
disruptions
cannot
be
predicted.
These
and
other
similar
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
The
fund's
performance
could
be
negatively
impacted
if
the
value
of
a
portfolio
holding
were
harmed
by
these
or
such
events.
Management
actively
monitors
the
risks
and
financial
impacts
arising
from
such
events.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
26
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
Each
year,
the
fund's
Board
of
Directors
(Board)
considers
the
continuation
of
the
investment
management
agreement
(Advisory
Contract)
between
the
fund
and
its
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser).
In
that
regard,
at
a
meeting
held
on
March
11-12,
2024
(Meeting),
the
Board,
including
all
of
the
fund's
independent
directors
present
in
person
at
the
Meeting,
approved
the
continuation
of
the
fund's
Advisory
Contract.
At
the
Meeting,
the
Board
considered
the
factors
and
reached
the
conclusions
described
below
relating
to
the
selection
of
the
Adviser
and
the
approval
of
the
Advisory
Contract.
The
independent
directors
were
assisted
in
their
evaluation
of
the
Advisory
Contract
by
independent
legal
counsel
from
whom
they
received
separate
legal
advice
and
with
whom
they
met
separately.
In
providing
information
to
the
Board,
the
Adviser
was
guided
by
a
detailed
set
of
requests
for
information
submitted
by
independent
legal
counsel
on
behalf
of
the
independent
directors.
In
considering
and
approving
the
continuation
of
the
Advisory
Contract,
the
Board
considered
the
information
it
believed
was
relevant,
including,
but
not
limited
to,
the
information
discussed
below.
The
Board
considered
not
only
the
specific
information
presented
in
connection
with
the
Meeting,
but
also
the
knowledge
gained
over
time
through
interaction
with
the
Adviser
about
various
topics.
The
Board
meets
regularly
and,
at
each
of
its
meetings,
covers
an
extensive
agenda
of
topics
and
materials
and
considers
factors
that
are
relevant
to
its
annual
consideration
of
the
renewal
of
the
T.
Rowe
Price
funds'
advisory
contracts,
including
performance
and
the
services
and
support
provided
to
the
funds
and
their
shareholders.
Services
Provided
by
the
Adviser
The
Board
considered
the
nature,
quality,
and
extent
of
the
services
provided
to
the
fund
by
the
Adviser.
These
services
included,
but
were
not
limited
to,
directing
the
fund's
investments
in
accordance
with
its
investment
program
and
the
overall
management
of
the
fund's
portfolio,
as
well
as
a
variety
of
related
activities
such
as
financial,
investment
operations,
and
administrative
services;
compliance;
maintaining
the
fund's
records
and
registrations;
and
shareholder
communications.
The
Board
also
reviewed
the
background
and
experience
of
the
Adviser's
senior
management
team
and
investment
personnel
involved
in
the
management
of
the
fund,
as
well
as
the
Adviser's
compliance
record.
The
Board
concluded
that
the
information
it
considered
with
respect
to
the
nature,
quality,
and
extent
of
the
services
provided
by
the
Adviser,
as
well
as
the
other
factors
considered
at
the
Meeting,
supported
the
Board's
approval
of
the
continuation
of
the
Advisory
Contract.
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
27
Investment
Performance
of
the
Fund
The
Board
took
into
account
discussions
with
the
Adviser
and
detailed
reports
that
it
regularly
receives
throughout
the
year
on
relative
and
absolute
performance
for
the
T.
Rowe
Price
funds.
In
connection
with
the
Meeting,
the
Board
reviewed
information
provided
by
the
Adviser
that
compared
the
fund's
total
returns,
as
well
as
a
wide
variety
of
other
previously
agreed-upon
performance
measures
and
market
data,
against
relevant
benchmark
indexes
and
peer
groups
of
funds
with
similar
investment
programs
for
various
periods
through
December
31,
2023.
Additionally,
the
Board
reviewed
the
fund's
relative
performance
information
as
of
September
30,
2023,
which
ranked
the
returns
of
the
fund's
Investor
Class
for
various
periods
against
a
universe
of
funds
with
similar
investment
programs
selected
by
Broadridge,
an
independent
provider
of
mutual
fund
data.
In
the
course
of
its
deliberations,
the
Board
considered
performance
information
provided
throughout
the
year
and
in
connection
with
the
Advisory
Contract
review
at
the
Meeting,
as
well
as
information
provided
during
investment
review
meetings
conducted
with
portfolio
managers
and
senior
investment
personnel
during
the
course
of
the
year
regarding
the
fund's
performance.
The
Board
also
considered
relevant
factors,
such
as
overall
market
conditions
and
trends
that
could
adversely
impact
the
fund's
performance,
the
length
of
the
fund's
performance
track
record,
and
how
closely
the
fund's
strategies
align
with
its
benchmarks
and
peer
groups.
The
Board
concluded
that
the
information
it
considered
with
respect
to
the
fund's
performance,
as
well
as
the
other
factors
considered
at
the
Meeting,
supported
the
Board's
approval
of
the
continuation
of
the
Advisory
Contract.
Costs,
Benefits,
Profits,
and
Economies
of
Scale
The
Board
reviewed
detailed
information
regarding
the
revenues
received
by
the
Adviser
under
the
Advisory
Contract
and
other
direct
and
indirect
benefits
that
the
Adviser
(and
its
affiliates)
may
have
realized
from
its
relationship
with
the
fund.
In
considering
soft-dollar
arrangements
pursuant
to
which
research
may
be
received
from
broker-dealers
that
execute
the
fund's
portfolio
transactions,
the
Board
noted
that
during
2023
the
Adviser
paid
the
costs
of
research
services
for
all
client
accounts
that
it
advises,
including
the
T.
Rowe
Price
funds.
However,
effective
January
1,
2024,
the
Adviser
will
begin
using
brokerage
commissions
in
connection
with
certain
T.
Rowe
Price
funds'
securities
transactions
to
pay
for
research
when
permissible.
The
Board
received
information
on
the
estimated
costs
incurred
and
profits
realized
by
the
Adviser
from
managing
the
T.
Rowe
Price
funds.
The
Board
also
reviewed
estimates
of
the
profits
realized
from
managing
the
fund
in
particular,
and
the
Board
concluded
that
the
Adviser's
profits
were
reasonable
in
light
of
the
services
provided
to
the
fund.
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
28
The
Board
also
considered
whether
the
fund
benefits
under
the
fee
levels
set
forth
in
the
Advisory
Contract
or
otherwise
from
any
economies
of
scale
realized
by
the
Adviser.
Under
the
Advisory
Contract,
the
fund
pays
a
fee
to
the
Adviser
for
investment
management
services
based
on
the
fund's
average
daily
net
assets
and
the
fund
pays
its
own
expenses
of
operations.
Assets
of
the
fund
are
included
in
the
calculation
of
the
group
fee
rate,
which
serves
as
a
component
of
the
management
fee
for
many
other
T.
Rowe
Price
funds
and
declines
at
certain
asset
levels
based
on
the
combined
average
net
assets
of
most
of
the
T.
Rowe
Price
funds
(including
the
fund).
Although
the
fund
does
not
have
a
group
fee
component
to
its
management
fee,
its
assets
are
included
in
the
calculation
because
certain
resources
utilized
to
operate
the
fund
are
shared
with
other
T.
Rowe
Price
funds.
The
fund's
shareholders
also
benefit
from
potential
economies
of
scale
through
a
decline
in
certain
operating
expenses
as
the
fund
grows
in
size.
However,
the
fund
is
also
subject
to
contractual
expense
limitations
that
require
the
Adviser
to
waive
its
fees
and/or
bear
any
expenses
that
would
otherwise
cause
the
expenses
of
a
share
class
of
the
fund
to
exceed
a
certain
percentage
based
on
the
class's
net
assets.
The
expense
limitations
mitigate
the
potential
for
an
increase
in
operating
expenses
above
a
certain
level
that
could
impact
shareholders.
In
addition,
the
Board
noted
that
the
fund
potentially
shares
in
indirect
economies
of
scale
through
the
Adviser's
ongoing
investments
in
its
business
in
support
of
the
T.
Rowe
Price
funds,
including
investments
in
trading
systems,
technology,
and
regulatory
support
enhancements,
and
the
ability
to
possibly
negotiate
lower
fee
arrangements
with
third-party
service
providers.
The
Board
concluded
that
the
advisory
fee
structure
for
the
fund
provides
for
a
reasonable
sharing
of
benefits
from
any
economies
of
scale
with
the
fund's
investors.
Fees
and
Expenses
The
Board
was
provided
with
information
regarding
industry
trends
in
management
fees
and
expenses.
Among
other
things,
the
Board
reviewed
data
for
peer
groups
that
were
compiled
by
Broadridge,
which
compared:
(i)
contractual
management
fees,
actual
management
fees,
nonmanagement
expenses,
and
total
expenses
of
the
Investor
Class
of
the
fund
with
a
group
of
competitor
funds
selected
by
Broadridge
(Expense
Group)
and
(ii)
actual
management
fees,
nonmanagement
expenses,
and
total
expenses
of
the
Investor
Class
of
the
fund
with
a
broader
set
of
funds
within
the
Lipper
investment
classification
(Expense
Universe).
The
Board
considered
the
fund's
contractual
management
fee
rate,
actual
management
fee
rate
(which
reflects
the
management
fees
actually
received
from
the
fund
by
the
Adviser
after
any
applicable
waivers,
reductions,
or
reimbursements),
operating
expenses,
and
total
expenses
(which
reflect
the
net
total
expense
ratio
of
the
fund
after
any
waivers,
reductions,
or
reimbursements)
in
comparison
with
the
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
29
information
for
the
Broadridge
peer
groups.
Broadridge
generally
constructed
the
peer
groups
by
seeking
the
most
comparable
funds
based
on
similar
investment
classifications
and
objectives,
expense
structure,
asset
size,
and
operating
components
and
attributes
and
ranked
funds
into
quintiles,
with
the
first
quintile
representing
the
funds
with
the
lowest
relative
expenses
and
the
fifth
quintile
representing
the
funds
with
the
highest
relative
expenses.
The
information
provided
to
the
Board
indicated
that
the
fund's
contractual
management
fee
ranked
in
the
second
quintile
(Expense
Group),
the
fund's
actual
management
fee
rate
ranked
in
the
fourth
quintile
(Expense
Group
and
Expense
Universe),
and
the
fund's
total
expenses
ranked
in
the
fourth
quintile
(Expense
Group)
and
fifth
quintile
(Expense
Universe).
The
Adviser
provided
the
Board
with
additional
information
with
respect
to
the
fund's
relative
actual
management
fees
and
total
expenses
ranking
in
the
fourth
and
fifth
quintiles.
The
Board
reviewed
and
considered
the
information
provided
relating
to
the
fund,
including
other
funds
in
the
peer
group,
and
other
factors
that
the
Board
determined
to
be
relevant.
The
Board
also
reviewed
the
fee
schedules
for
other
investment
portfolios
with
similar
mandates
that
are
advised
or
subadvised
by
the
Adviser
and
its
affiliates,
including
separately
managed
accounts
for
institutional
and
individual
investors;
subadvised
funds;
and
other
sponsored
investment
portfolios,
including
collective
investment
trusts
and
pooled
vehicles
organized
and
offered
to
investors
outside
the
United
States.
Management
provided
the
Board
with
information
about
the
Adviser's
responsibilities
and
services
provided
to
subadvisory
and
other
institutional
account
clients,
including
information
about
how
the
requirements
and
economics
of
the
institutional
business
are
fundamentally
different
from
those
of
the
proprietary
mutual
fund
business.
The
Board
considered
information
showing
that
the
Adviser's
mutual
fund
business
is
generally
more
complex
from
a
business
and
compliance
perspective
than
its
institutional
account
business
and
considered
various
relevant
factors,
such
as
the
broader
scope
of
operations
and
oversight,
more
extensive
shareholder
communication
infrastructure,
greater
asset
flows,
heightened
business
risks,
and
differences
in
applicable
laws
and
regulations
associated
with
the
Adviser's
proprietary
mutual
fund
business.
In
assessing
the
reasonableness
of
the
fund's
management
fee
rate,
the
Board
considered
the
differences
in
the
nature
of
the
services
required
for
the
Adviser
to
manage
its
mutual
fund
business
versus
managing
a
discrete
pool
of
assets
as
a
subadviser
to
another
institution's
mutual
fund
or
for
an
institutional
account
and
that
the
Adviser
generally
performs
significant
additional
services
and
assumes
greater
risk
in
managing
the
fund
and
other
T.
Rowe
Price
funds
than
it
does
for
institutional
account
clients,
including
subadvised
funds.
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
T.
ROWE
PRICE
Tax-Exempt
Money
Fund
30
On
the
basis
of
the
information
provided
and
the
factors
considered,
the
Board
concluded
that
the
fees
paid
by
the
fund
under
the
Advisory
Contract
are
reasonable.
Approval
of
the
Advisory
Contract
As
noted,
the
Board
approved
the
continuation
of
the
Advisory
Contract.
No
single
factor
was
considered
in
isolation
or
to
be
determinative
to
the
decision.
Rather,
the
Board
concluded,
in
light
of
a
weighting
and
balancing
of
all
factors
considered,
that
it
was
in
the
best
interests
of
the
fund
and
its
shareholders
for
the
Board
to
approve
the
continuation
of
the
Advisory
Contract
(including
the
fees
to
be
charged
for
services
thereunder).
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
100
East
Pratt
Street
Baltimore,
MD
21202
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
F52-051
10/24
Item 8. Changes in and Disagreements with Accountants for Open-EndManagement Investment Companies.
Not applicable.
Item 9. Proxy Disclosures for Open-EndManagement Investment Companies.
Not applicable.
Item 10. Remuneration Paid to Directors, Officers, and Others of Open-EndManagement Investment Companies.
Remuneration paid to Directors is included in Item 7 of this Form N-CSR.
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contract.
If applicable, see Item 7.
Item 12. Disclosure of Proxy Voting Policies and Procedures for Closed-EndManagement Investment Companies.
Not applicable.
Item 13. Portfolio Managers of Closed-EndManagement Investment Companies.
Not applicable.
Item 14. Purchases of Equity Securities by Closed-EndManagement Investment Company and Affiliated Purchasers.
Not applicable.
Item 15. Submission of Matters to a Vote of Security Holders.
There has been no change to the procedures by which shareholders may recommend nominees to the registrant's board of directors.
Item 16. Controls and Procedures.
(a) The registrant's principal executive officer and principal financial officer have evaluated the registrant's disclosure controls and procedures within 90 days of this filing and have concluded that the registrant's disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSRwas recorded, processed, summarized, and reported timely.
(b) The registrant's principal executive officer and principal financial officer are aware of no change in the registrant's internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.
Item 17. Disclosure of Securities Lending Activities for Closed-EndManagement Investment Companies.
Not applicable.
Item 18. Recovery of Erroneously Awarded Compensation.
Not applicable.
Item 19. Exhibits.
| (a)(1) |
The registrant's code of ethics pursuant to Item 2 of Form N-CSRis filed with the registrant's annual Form N-CSR. |
|
| (2) |
Listing standards relating to recovery of erroneously awarded compensation: Not applicable. |
|
| (3) |
Separate certifications by the registrant's principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached. |
| (b) |
A certification by the registrant's principal executive officer and principal financial officer, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(b) under the Investment Company Act of 1940, is attached. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| T. Rowe Price Tax-Exempt Money Fund, Inc. |
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date | October 18, 2024 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| By |
/s/ David Oestreicher |
|||
| David Oestreicher | ||||
| Principal Executive Officer | ||||
| Date |
October 18, 2024 |
| By |
/s/ Alan S. Dupski |
|||
| Alan S. Dupski | ||||
| Principal Financial Officer | ||||
| Date |
October 18, 2024 |